Teva Announces Launch of an authorized generic of Flector 1 Patch 1.3%
Teva Pharmaceutical Industries announced the launch of an authorized generic of Flector 1 Patch, 1.3%, in the U.S. Diclofenac epolamine topical patch, 1.
Pharmacy
Publix and Flagler Health+ partner to improve care
Publix Pharmacy and Flagler Health+ recently announced an exclusive collaboration to improve the delivery of health care to the residents of St. Johns County, Fla. The collaboration initially includes three Flagler Health+ branded telehealth sites at Publix locations throughout St.
Walgreens launches cancer patient support program
Walgreens Monday launched “Feel More Like You,” a first-of-its-kind pharmacy, health and beauty service available at no cost to help people living with cancer manage the medical and physical changes associated with cancer treatment.
NACDS, NCPA brief Congressional Doctors Caucus on DIR fee reform
NACDS and the National Community Pharmacists Association (NCPA) held a briefing this week for the Congressional Doctors Caucus. The Caucus, chaired by Rep. Phil Roe (R, Tenn.
Camber rolls out generic Lovaza
Camber Pharmaceuticals has announced the addition of omega-3 acid ethyl esters capsules to our growing portfolio of products. Omega-3 acid ethyl esters capsules are the generic version of Lovaza from GlaxoSmithKline and is used to lower levels of Triglycerides and may raise “good” cholesterol.
Amazon vet Kabbani reported to run new pharmacy business
SEATTLE – According to published reports from CNBC and other sources, Amazon has named 14-year company veteran Nader Kabbani to run its new pharmacy business, including the team that came in through last year’s acquisition of PillPack.
Florida Pharmaceutical Products and Quinn Pharmaceuticals team
Stason Pharmaceuticals, a global pharmaceutical group based in Irvine, Calif. recently entered into a strategic alliance with Florida Pharmaceutical Products, (FPP) for Stason subsidiary Quinn Pharmaceuticals. Financial terms were not disclosed.
Titan teams with AllianceRx Walgreens Prime
Titan Pharmaceuticals announced Thursday the execution of a specialty pharmacy distribution and services agreement with AllianceRx Walgreens Prime that will expand patient access to treatment with Probuphine (buprenorphine) implant, Titan’s unique six-month maintenance treatment for opioid use disor
HDA issues statement on enhanced DEA ARCOS data monitoring
Healthcare Distribution Alliance (HDA) president and chief executive officer John Gray issued the following statement in response to the Drug Enforcement Administration’s (DEA) announcement of an enhanced data tool to support additional information sharing with pharmaceutical distributors and manuf
Jeff Flake and Katherine Wintsch to speak at NACDS Annual Meeting
Former Arizona Sen. Jeff Flake and Katherine Wintsch, founder and CEO of The Mom Complex will speak at the National Association of Chain Drug Stores Annual Meeting, slated for April 27-30 at The Breakers in Palm Beach, Florida.
Oklahoma City, Okla. and Greensboro, N.C. tops in flu activity
Oklahoma City, Okla. and Greensboro, N.C. were the top cities for flu activity in Walgreens Flu Index for Week Ending February 23.
Lupin launches generic minocycline hydrochloride ER tablets
Lupin announced the launch of minocycline hydrochloride extended-release tablets USP 55mg, having received an approval from the United States Food and Drug Administration (FDA) earlier.
Rite Aid rolls out prescription drug safety program in Ohio schools
In an effort to help address adolescent drug abuse and misuse in Ohio, The Rite Aid Foundation is bringing the Prescription Drug Safety program, an innovative digital course about prescription drug abuse prevention, to Akron-area high schools.
Pharmacy champion McMorris Rodgers leads letter to HHS on DIR reform
Rep. Cathy McMorris Rodgers (R, Wash.
PCMA launches new advertising campaign
The Pharmaceutical Care Management Association (PCMA) is launching a new print and digital ad campaign – “Protect the Savings” – to defend the savings that pharmacy benefit managers (PBMs) negotiate from drugmakers, and warn against the Administration’s newly proposed regulation that would eliminate
SDM drives slight gain in Loblaw’s Q4 sales
Shoppers Drug Mart propelled a slight uptick in parent Loblaw Cos.’ fourth quarter sales. SDM posted 1.9% same-store sales growth for the quarter ended December 29 compared to a year earlier, with pharmacy same-store sales growth of 0.6% and front store same-store sales growth of 2.8%.